A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Buprenorphine, Calcium Chloride8

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	640 mg	PO	not captured	standing	pages 190, 453
Mild to moderate pain	peds	1.25 mL	PO	not captured	standing	page 190
Mild to moderate pain	peds	1.25 mL	PO	not captured	standing	pages 190, 453
Mild to moderate pain	peds	10 mL	PO	not captured	standing	page 190
Mild to moderate pain	peds	2.5 mL	PO	not captured	standing	page 190
Mild to moderate pain	peds	20 mL	PO	not captured	standing	page 190
Mild to moderate pain	peds	3.75 mL	PO	not captured	standing	page 190
Mild to moderate pain	peds	5 mL	PO	not captured	standing	page 190

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	6 mg	IV	not captured	standing	pages 125, 455
Other	adult	6 mg	IV	not captured	standing	page 455
Other	peds	0.1 mg/kg	IV	not captured	standing	pages 125, 455
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	page 455
Wide-complex tachycardia	adult	6 mg	IV	not captured	standing	pages 125, 455
Wide-complex tachycardia	peds	0.1 mg/kg	IV	not captured	standing	pages 125, 455

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2.5 mg	NEB	not captured	standing	pages 147, 148, 149, 150, 456, 457
Other	adult	2.5 mg	NEB	not captured	standing	page 150
Other	adult	2.5 mg	NEB	not captured	standing	pages 456, 457
Other	peds	2.5 mg	NEB	not captured	standing	pages 147, 148, 149, 150, 456, 457
Other	peds	2.5 mg	NEB	not captured	standing	pages 456, 457

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	150 mg	IV/IO	not captured	standing	page 459
Other	adult	300 mg	IV/IO	not captured	standing	pages 85, 458, 459
Other	peds	5 mg/kg	IV/IO	not captured	standing	pages 85, 458, 459
Other	peds	5 mg/kg	IV/IO	not captured	standing	page 459
Wide-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	pages 458, 459

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	324 mg	PO	not captured	standing	pages 133, 454
Other	adult	324 mg	PO	not captured	standing	page 454

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	0.5 mg	IV/IO	not captured	standing	pages 130, 460, 461
Bradycardia	adult	0.5 mg	IV	not captured	standing	pages 460, 461
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 130, 460, 461
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	pages 460, 461
Other	adult	1 mg	IV/IO	not captured	standing	page 130
Other	adult	1–2 mg	IV/IO	not captured	standing	pages 327, 461
Other	adult	2 mg	IM	not captured	standing	pages 460, 461
Other	adult	2 mg	IM	not captured	standing	page 328
Other	adult	2 mg	IM	not captured	standing	pages 460, 461
Other	peds	0.02 mg/kg	IV/IO	not captured	standing	page 130
Other	peds	0.05 mg/kg	IV/IO	not captured	standing	pages 327, 461
Other	peds	0.5 mg	IM	not captured	standing	pages 460, 461
Other	peds	1 mg	IM	not captured	standing	page 324
Other	peds	2 mg	IM	not captured	standing	pages 460, 461

Buprenorphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	16 mg	SL	not captured	standing	page 529
Other	adult	8–16 mg	SL	not captured	standing	pages 462, 529

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 g	IV/IO	not captured	standing	page 463
Beta-blocker / calcium-channel-blocker overdose	adult	1 g	IV	not captured	standing	page 246
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV/IO	not captured	standing	page 463
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV	not captured	standing	page 246
Cardiac arrest	adult	1 g	IV	not captured	standing	page 463
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	pages 78, 86, 228, 463
Hyperkalemia	peds	20 mg/kg	IV/IO	not captured	standing	pages 78, 86, 228, 463
Other	adult	1 g	IV/IO	not captured	standing	page 463
Other	adult	1 g	IV/IO	not captured	standing	pages 302, 303, 304
Other	adult	1 g	IV	not captured	standing	page 463
Other	adult	10 mL	IV/IO	not captured	standing	page 78
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 463
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 78
Trauma / hemorrhage	adult	1 g	IV/IO	not captured	standing	pages 302, 303, 304

D–F Dextrose, Diazepam, Diphenhydramine, Enalaprilat, Epinephrine, Esmolol, Fentanyl7

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	100 mL	IV/IO	not captured	standing	page 215
Hypoglycemia	peds	5 mL/kg	IV/IO	not captured	standing	pages 215, 464
Hypoglycemia	peds	5 mL/kg	IV/IO	not captured	standing	page 215

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10 mg	IM	not captured	standing	page 465
Other	adult	2–10 mg	IV/IO	not captured	standing	page 465
Other	adult	2–10 mg	IV	not captured	standing	page 465
Other	peds	0.3 mg/kg	IM	not captured	standing	page 465
Other	peds	0.3 mg/kg	IV/IO	not captured	standing	page 465
Other	peds	0.3 mg/kg	IV/IO/IM	not captured	standing	page 326
Other	peds	0.3 mg/kg	IV/IO/IM	not captured	standing	page 465

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	50 mg	IV/IO/IM	not captured	standing	page 168
Allergic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 168
Anaphylaxis	adult	50 mg	IV/IO/IM	not captured	standing	page 168
Anaphylaxis	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 168
Dystonic reaction	adult	50 mg	IV/IM	not captured	standing	page 171
Other	adult	25 mg	IV/IM	not captured	standing	page 135
Other	adult	25 mg	IV	not captured	standing	page 274
Other	adult	25–75 mg	IV/IM	not captured	standing	page 466
Other	peds	1 mg/kg	IV/IM	not captured	standing	page 466

Enalaprilat

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	1.25 mg	IV	not captured	standing	page 138
Other	adult	1.25 mg	IV	not captured	standing	page 138
Other	adult	1.25 mg	IV	not captured	standing	page 138

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3–0.5 mg	IM	not captured	standing	pages 148, 167, 468, 469
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	pages 148, 167, 468, 469
Asthma / bronchospasm	adult	0.3–0.5 mg	IM	not captured	standing	pages 148, 468, 469
Asthma / bronchospasm	peds	0.01 mg/kg	IM	not captured	standing	pages 148, 468, 469
Bradycardia	adult	2–10 mcg	IV/IO	not captured	standing	pages 131, 469
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 78, 84, 468, 469
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 78, 84, 468, 469
Other	adult	0.3 mg	IM	not captured	standing	page 148
Other	adult	0.5 mg	IM	not captured	standing	pages 167, 468, 469
Other	adult	1 mL	IV/IO	not captured	standing	pages 131, 405
Other	peds	0.01 mg/kg	IV/IO	not captured	standing	page 469
Other	peds	0.15 mg	IM	not captured	standing	page 148
Other	peds	0.3 mg	IM	not captured	standing	pages 167, 468, 469

Esmolol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5 mg/kg	IV/IO	not captured	standing	pages 92, 470
Other	adult	0.5 mg/kg	IV/IO	not captured	standing	pages 126, 470
Other	adult	0.5 mg/kg	IV/IO	not captured	standing	pages 126, 470

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 mcg/kg	IV/IO/IM/IN	not captured	standing	page 192
Other	adult	1 mcg/kg	IV/IO	not captured	standing	page 238
Other	adult	25–100 mcg	IV/IO	not captured	standing	pages 101, 156
Other	adult	50–100 mcg	IV	not captured	standing	pages 135, 273, 471
Other	peds	0.5 mcg/kg	IV/IO	not captured	standing	pages 101, 156
Other	peds	1 mcg/kg	IV	not captured	standing	pages 135, 273, 471
Other	peds	1 mcg/kg	IV	not captured	standing	page 135
Other	peds	1 mcg/kg	IV/IO/IM/IN	not captured	standing	page 192
Other	peds	1 mcg/kg	IV/IO	not captured	standing	page 238
Other	peds	1 mcg/kg	IV/IO/IN	not captured	standing	pages 273, 471
Mild to moderate pain	adult	25–50 mcg	IV	not captured	standing	pages 135, 192, 471
Mild to moderate pain	peds	1 mcg/kg	IV	not captured	standing	pages 135, 192, 471

G–L Glucagon, Haloperidol, Hydrocortisone, Hydroxocobalamin, Ipratropium, Ketamine, Ketorolac, Lidocaine8

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	1 mg	IV/IO/IM/IN	not captured	standing	pages 472, 473
Anaphylaxis	peds	1 mg	IV/IO/IM/IN	not captured	standing	pages 472, 473
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV/IO/IM/IN	not captured	standing	pages 472, 473
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV/IO/IM/IN	not captured	standing	pages 472, 473
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV	not captured	standing	page 246
Beta-blocker / calcium-channel-blocker overdose	peds	1 mg	IV/IO/IM/IN	not captured	standing	pages 472, 473
Beta-blocker / calcium-channel-blocker overdose	peds	1 mg	IV/IO/IM/IN	not captured	standing	pages 472, 473
Beta-blocker / calcium-channel-blocker overdose	peds	1 mg	IV	not captured	standing	page 246
Hypoglycemia	adult	1 mg	IM/IN	not captured	standing	pages 472, 473
Hypoglycemia	peds	0.5 mg	IM/IN	not captured	standing	pages 472, 473
Other	adult	1 mg	IM/IN	not captured	standing	pages 215, 472, 473
Other	peds	0.5 mg	IV/IO/IM/IN	not captured	standing	pages 168, 473
Other	peds	1 mg	IM/IN	not captured	standing	pages 215, 472, 473

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2.5 mg	IM	not captured	standing	pages 208, 475, 476
Other	adult	5 mg	IM	not captured	standing	pages 475, 476
Other	peds	2 mg	IM	not captured	standing	pages 208, 475, 476
Other	peds	5 mg	IM	not captured	standing	pages 475, 476

Hydrocortisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	100 mg	IV/IO/IM	not captured	standing	page 477
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 477

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV	not captured	standing	page 478
Cyanide poisoning	peds	70 mg/kg	IV	not captured	standing	page 478
Other	adult	5 g	IV	not captured	standing	page 255
Other	adult	5 g	IV	not captured	standing	page 478
Other	peds	70 mg/kg	IV	not captured	standing	page 255
Other	peds	70 mg/kg	IV	not captured	standing	page 478

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	500 mcg	NEB	not captured	standing	page 479
Asthma / bronchospasm	peds	500 mcg	NEB	not captured	standing	page 479
Other	adult	500 mcg	NEB	not captured	standing	page 150

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	1 mg/kg	IV/IO	not captured	standing	page 480
Other	adult	0.5 mg/kg	IV/IO	not captured	standing	page 481
Other	adult	0.5 mg/kg	IV/IO	not captured	standing	pages 100, 155, 481
Other	adult	0.5 mg/kg	IM/IN	not captured	standing	page 193
Other	peds	0.5 mg/kg	IV/IO	not captured	standing	pages 100, 155, 481
Other	peds	0.5 mg/kg	IM/IN	not captured	standing	page 193
Mild to moderate pain	adult	0.2 mg/kg	IV/IO/IM	not captured	standing	page 480
RSI induction	adult	2 mg/kg	IV/IO	not captured	standing	pages 480, 481
RSI induction	peds	2 mg/kg	IV/IO	not captured	standing	pages 480, 481

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV	not captured	standing	pages 194, 482
Mild to moderate pain	adult	30 mg	IM	not captured	standing	pages 194, 482
Mild to moderate pain	peds	0.5 mg/kg	IV	not captured	standing	pages 194, 482
Mild to moderate pain	peds	1 mg/kg	IM	not captured	standing	pages 194, 482

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1.5 mg/kg	IV/IO	not captured	standing	page 484
Other	adult	20–40 mg	IO	not captured	standing	page 484
Other	adult	4 mL	IO	not captured	standing	page 413
Post-ROSC care	adult	0.5 mg/kg	IV/IO	not captured	standing	page 484
Post-ROSC care	peds	0.5 mg/kg	IV/IO	not captured	standing	page 484
Wide-complex tachycardia	adult	1 mg/kg	IV/IO	not captured	standing	page 484
Wide-complex tachycardia	peds	1 mg/kg	IV/IO	not captured	standing	page 484
VF / pulseless VT	adult	1 mg/kg	IV/IO	not captured	standing	pages 483, 484
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	pages 483, 484

M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Ondansetron, Oral Glucose8

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 g	IV	not captured	standing	page 486
Asthma / bronchospasm	peds	25–50 mg/kg	IV	not captured	standing	page 486
Eclampsia / pre-eclampsia	adult	4 g	IV	not captured	standing	page 486
Other	adult	2 g	IV/IO	not captured	standing	pages 85, 485, 486
Other	adult	2 g	IV	not captured	standing	page 486
Other	adult	2 g	IV/IO	not captured	standing	pages 121, 486
Other	peds	25–50 mg/kg	IV/IO	not captured	standing	pages 85, 485, 486
Other	peds	25–50 mg/kg	IV	not captured	standing	page 486
Other	peds	50 mg/kg	IV/IO	not captured	standing	pages 121, 486

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	125 mg	IV/IO/IM	not captured	standing	page 487
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 487
Asthma / bronchospasm	adult	125 mg	IV/IO/IM	not captured	standing	page 487
Asthma / bronchospasm	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 487
COPD	adult	125 mg	IV/IO/IM	not captured	standing	page 487
COPD	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 487
Other	adult	125 mg	IV/IM	not captured	standing	page 149
Other	peds	2 mg/kg	IV/IM	not captured	standing	page 149

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2–5 mg	IV/IO/IN	not captured	standing	page 489
Other	adult	2–5 mg	IV/IN	not captured	standing	page 489
Other	adult	2–5 mg	IV/IO	not captured	standing	page 249
Other	adult	2–5 mg	IV/IO	not captured	standing	page 450
Other	adult	5 mg	IM	not captured	standing	pages 204, 489
Other	adult	5 mg	IV/IO	not captured	standing	pages 204, 489
Other	adult	5 mg	IN	not captured	standing	pages 204, 489
Other	adult	5 mg	IN	not captured	standing	page 450
Other	adult	5 mg	IM	not captured	standing	page 450
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 204, 489
Other	peds	0.1 mg/kg	IV/IO/IN	not captured	standing	page 489
Other	peds	0.1 mg/kg	IV/IN	not captured	standing	page 489
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	page 249
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	page 450
Other	peds	0.2 mg/kg	IM	not captured	standing	pages 204, 489
Other	peds	0.2 mg/kg	IN	not captured	standing	pages 204, 489
Other	peds	0.2 mg/kg	IN	not captured	standing	page 249
Other	peds	0.2 mg/kg	IN	not captured	standing	page 450
Other	peds	0.2 mg/kg	IM	not captured	standing	page 450
Other	peds	0.2 mg/kg	IM	not captured	standing	pages 326, 489
Seizure	adult	5 mg	IM	not captured	standing	pages 204, 489
Seizure	peds	0.2 mg/kg	IM	not captured	standing	pages 204, 489

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	2 mg	IV	not captured	standing	page 491
Other	adult	2 mg	IV	not captured	standing	page 491
Other	peds	0.1 mg/kg	IV	not captured	standing	page 491
Other	peds	0.1 mg/kg	IV	not captured	standing	page 135

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	2 mg	IN	not captured	standing	pages 152, 492
Opioid overdose	adult	2 mg	IV/IM/IN	not captured	standing	pages 152, 492
Opioid overdose	peds	0.1 mg/kg	IN	not captured	standing	pages 152, 492
Opioid overdose	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 152, 492
Other	peds	0.1 mg/kg	IV/IO/ET	not captured	standing	page 117

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	pages 133, 134, 493
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	pages 138, 494
Other	adult	0.4 mg	SL	not captured	standing	pages 138, 494

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/IO/IM/ODT	not captured	standing	pages 135, 210, 239, 495, 496
Nausea / vomiting	peds	0.15 mg/kg	IV/IO/IM/ODT	not captured	standing	pages 135, 210, 239, 495, 496
Other	adult	4 mg	IV	not captured	standing	page 135
Other	adult	4 mg	IV/IO/ODT	not captured	standing	pages 210, 496
Other	adult	4 mg	IM	not captured	standing	pages 210, 496
Other	peds	0.15 mg/kg	IV	not captured	standing	page 135
Other	peds	0.15 mg/kg	IM	not captured	standing	pages 210, 496
Other	peds	0.15 mg/kg	IV/IO/PO	not captured	standing	pages 210, 496

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypothermia	adult	24–50 g	PO/SL	not captured	standing	page 241

P–R Pralidoxime, Prednisone, Prochlorperazine, Racemic Epinephrine4

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Organophosphate poisoning	adult	600 mg	IM	not captured	standing	pages 324, 498
Organophosphate poisoning	peds	600 mg	IM	not captured	standing	pages 324, 498
Other	adult	1.8 g	IM	not captured	standing	page 328
Other	adult	600 mg	IM	not captured	standing	pages 323, 498
Other	adult	600 mg	IM	not captured	standing	page 498
Other	peds	600 mg	IM	not captured	standing	pages 323, 498

Prednisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	60 mg	PO	not captured	standing	pages 149, 150, 499
Asthma / bronchospasm	adult	60 mg	PO	not captured	standing	pages 149, 150, 499
Asthma / bronchospasm	peds	1–2 mg/kg	PO	not captured	standing	pages 149, 150, 499
Asthma / bronchospasm	peds	1–2 mg/kg	PO	not captured	standing	pages 149, 150, 499
COPD	adult	60 mg	PO	not captured	standing	pages 149, 150, 499
COPD	peds	1–2 mg/kg	PO	not captured	standing	pages 149, 150, 499

Prochlorperazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	10 mg	IV/IM	not captured	standing	pages 135, 274
Nausea / vomiting	adult	10 mg	IV/IM	not captured	standing	pages 135, 274
Other	adult	10 mg	IV	not captured	standing	page 274

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5 mL	NEB	not captured	standing	pages 151, 500
Other	adult	0.5 mL	NEB	not captured	standing	pages 149, 500
Other	adult	0.5 mL	NEB	not captured	standing	pages 149, 151, 500
Other	peds	0.25 mL	NEB	not captured	standing	pages 151, 500
Other	peds	0.25 mL	NEB	not captured	standing	pages 149, 500
Other	peds	0.5 mL	NEB	not captured	standing	pages 149, 151, 500

S–Z Sodium Bicarbonate, Tranexamic Acid, Whole Blood3

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	1 mEq/kg	IV/IO	not captured	standing	pages 79, 86, 249, 501
Agitation	peds	1 mEq/kg	IV/IO	not captured	standing	pages 79, 86, 249, 501
Hyperkalemia	adult	1 mEq/kg	IV/IO	not captured	standing	pages 78, 86, 501
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	pages 78, 86, 501
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 79, 86, 246, 501
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 79, 86, 93
Other	adult	1 mEq/kg	IV	not captured	standing	page 246
Other	adult	50 mEq	IV/IO	not captured	standing	page 249
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 79, 86, 246, 501
Other	peds	1 mEq/kg	IV	not captured	standing	page 246

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 g	IV/IO	not captured	standing	page 525
Other	adult	1 g	IV/IO	not captured	standing	page 445
Other	adult	1 g	IV/IO	not captured	standing	pages 301, 302, 503
Other	adult	1 g	IV/IO	not captured	standing	pages 302, 503, 525, 526
Other	peds	25 mg/kg	IV/IO	not captured	standing	page 526

Whole Blood

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	peds	1 unit	IV/IO	not captured	standing	page 526
Trauma / hemorrhage	adult	1 unit	IV/IO	not captured	standing	pages 525, 526
Trauma / hemorrhage	peds	10 mL/kg	IV/IO	not captured	standing	pages 525, 526

DC Fire and EMS

Drugs and doses38